Invasive Procedure Clinical Trial
— HYPICOfficial title:
HYPIC Hypnosis for Procedural Pain in the Intensive Care Unit
Verified date | November 2022 |
Source | Rennes University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Procedural pain in resuscitation is common in the conscious patient. However, analgesia and sedation may be impossible because of the acute pathology leading to resuscitation, comorbidities or the urgency of the invasive procedure. In addition, the use of analgesics and sedatives is responsible for adverse effects. In this context, hypnosis appears to be an additional analgesic tool that would reduce the consumption of analgesics and sedatives and thus reduce their side effects.
Status | Completed |
Enrollment | 80 |
Est. completion date | October 11, 2022 |
Est. primary completion date | January 25, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Major patient admitted to intensive care - Glasgow score = 15 - Necessity during the stay of making an invasive gesture among: - Thoracic drainage - Placement of a central venous catheter or a Swan-Ganz catheter - Establishment of a dialysis catheter - Introduction of an invasive arterial catheter - Patient giving free, informed and written consent - Patient affiliated to a social security scheme Non inclusion Criteria: - Procedure to be carried out in extreme urgency - Confusional state making hypnosis impossible, evaluated by CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) - Decompensated psychiatric illness - Patient sedated or intravenous analgesia continued at the time of the procedure - Patient intubated - Patient with a contraindication to sedation or analgesia at the time of the procedure - Patient receiving topical anesthesia before the start of the procedure - Major person subject to legal protection (court bail, curator, guardianship) or deprived of liberty - Patient already included in the study during the completion of a previous invasive procedure - Patient participating in a research involving an interventional human person (category 1) on an analgesic / sedative drug |
Country | Name | City | State |
---|---|---|---|
France | Rennes University Hospital | Rennes | |
France | Saint-Brieuc Hospital | Saint-Brieuc | Bretagne |
Lead Sponsor | Collaborator |
---|---|
Rennes University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain assessment | Oral assessment scale (0 : no pain - 10 : maximal pain) | Immediately after the end of the invasive procedure (Hour 0) | |
Secondary | Pain assessment | Oral assessment scale (0 : no pain - 10 : maximal pain) | The first hour after the end of the procedure (Hour 1) | |
Secondary | Morphine equivalent dose | Cumulative use of morphine-morphine analgesics in morphine equivalent during the procedure and the first hour after the end of the procedure (H1) | Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1) | |
Secondary | Sedatives dose | Cumulative use of sedatives during the procedure and the first hour after the end of the procedure (H1) | Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1) | |
Secondary | Local Anesthesia dose | Consumption of local anesthesia during the invasive procedure | Immediately after the end of the invasive procedure (Hour 0) | |
Secondary | Comfort scale | Comfort measured by the numerical comfort scale (0 no comfort - 10 most comfortable situation imaginable) | Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1) | |
Secondary | Anxiety | Patient anxiety measured by the numerical anxiety scale (0 no anxiety - 10 greatest anxiety imaginable) . | Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1) | |
Secondary | Duration | Duration of the invasive procedure including the period of hypnosis | Immediately after the end of the invasive procedure (Hour 0) | |
Secondary | Number of attempts and failures of the procedure | Number of attempts and failures of the procedure | The first hour after the end of the procedure (Hour 1) | |
Secondary | Adverse events | Number of adverse events occurring during the procedure (hematoma, failure to pose, ...) | The first hour after the end of the procedure (Hour 1) | |
Secondary | Nurse stress | Stress of the nurse in charge of the patient quantified by a numerical scale of evaluation (0 no stress - 10 greatest stress imaginable) | Immediately after the end of the invasive procedure (Hour 0) | |
Secondary | Length of stay in intensive care unit | Length of stay in intensive care unit, measured until D28 | Day 28 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04276506 -
Effect of Information Given and Music on the Care of Patient Who Will Undergo Coronary Angiography
|
N/A | |
Recruiting |
NCT04286438 -
Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure
|
Phase 3 | |
Terminated |
NCT03150303 -
Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology
|